Related Experiment Video
Updated: May 15, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor
1Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract:
Androgen receptor (AR) has essential roles during prostate cancer progression. With genome-wide AR-binding sites mapped to high resolution, studies have recently reported AR as a transcriptional repressor. How AR inhibits gene expression and how this contributes to prostate cancer, however, are incompletely understood. Through meta-analysis of microarray data, here we nominate nephroblastoma overexpressed (NOV) as a top androgen-repressed gene. We show that NOV is directly suppressed by androgen through the AR. AR occupies the NOV enhancer and communicates with the NOV promoter through DNA looping. AR activation recruits the polycomb group protein EZH2, which subsequently catalyzes histone H3 lysine 27 tri-methylation around the NOV promoter, thus leading to repressive chromatin remodeling and epigenetic silencing. Concordantly, AR and EZH2 inhibition synergistically restored NOV expression. NOV is downregulated in human prostate cancer wherein AR and EZH2 are upregulated. Functionally, NOV inhibits prostate cancer cell growth in vitro and in vivo. NOV reconstitution reverses androgen-induced cell growth and NOV knockdown drives androgen-independent cell growth. In addition, NOV expression is restored by hormone-deprivation therapies in mice and prostate cancer patients. Therefore, using NOV as a model gene we gained further understanding of the mechanisms underlying AR-mediated transcriptional repression. Our findings establish a tumor-suppressive role of NOV in prostate cancer and suggest that one important, but previously underestimated, manner by which AR contributes to prostate cancer progression is through inhibition of key tumor-suppressor genes.
Insights
Androgen receptor (AR) represses the tumor suppressor gene NOV in prostate cancer. Inhibiting AR and EZH2 restores NOV, reducing cancer growth and suggesting a new therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Androgen receptor (AR) plays a critical role in prostate cancer progression.
- Recent studies highlight AR's function as a transcriptional repressor, but mechanisms remain unclear.
Purpose of the Study:
- To elucidate the mechanisms of AR-mediated gene repression in prostate cancer.
- To identify AR-repressed genes and their role in tumor suppression.
Main Methods:
- Meta-analysis of microarray data to identify androgen-repressed genes.
- ChIP-seq to map AR-binding sites.
- Molecular assays to assess gene expression, protein recruitment (EZH2), and epigenetic modifications (H3K27me3).
- In vitro and in vivo functional studies using prostate cancer models.
Main Results:
- Nephroblastoma overexpressed (NOV) identified as a top androgen-repressed gene, directly suppressed by AR.
- AR recruits EZH2 to the NOV promoter, leading to epigenetic silencing via H3K27 tri-methylation.
- NOV is downregulated in prostate cancer, and its expression is inversely correlated with AR and EZH2 levels.
- NOV exhibits tumor-suppressive functions, inhibiting cell growth in vitro and in vivo.
- Restoring NOV expression reverses androgen-induced growth and suppresses androgen-independent growth.
Conclusions:
- AR-mediated repression of the tumor suppressor NOV is a key mechanism in prostate cancer progression.
- AR and EZH2 cooperate to epigenetically silence NOV, promoting tumor growth.
- NOV acts as a crucial tumor suppressor in prostate cancer.
- Targeting AR-mediated repression of NOV may offer novel therapeutic strategies.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs

